The French health care budget deficit is now expected to reach 32.2 billion French francs ($6.26 billion) in 1996, accounting for a huge share of a total social security deficit of 48.6 billion francs. The forecast comes from the Social Security Accounts Commission (CCSS) and, if accurate, makes nonsense of the modest economies that formed part of the Juppe plan announced in November last year. Medical fees and drug prescription spending has reportedly increased by 7.5% in the first four months of this year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze